Search - tctmd.com

Displaying 41 - 60 of 222

Sort: Relevancy | Date

Presentation TCT 2023

Prevail Paclitaxel Coated Balloon

Presenter: Jack Tan

October 25, 2023

Presentation TCT 2023

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Presenter: Young-Sun Park

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Presenter: Teruo Sekimoto

October 25, 2023

Presentation TCT 2023

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Presenter: Shao-Liang Chen

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

TCT 64: Very Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon After a Bare-Metal Stent for the Treatment of ST-Elevation Myocardial Infarction: 8-Year Results of a Randomized Clinical Trial (PEBSI Study)

Presenter: Arturo Garcia-Touchard

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

Presentation TCT 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

Presenter: Christos Rammos

September 17, 2022

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

Presentation ARCH 2022

Paclitaxel or Limus: What is the Future in Drug Eluting Therapies?

Presenter: Craig M. Walker

April 23, 2022

Presentation ACC 2022

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Presenter: Alexandra Lansky

April 04, 2022

News Conference News TCT 2021

DCBs in Coronaries? Some Good News, but More Work Needed

L.A. McKeown

November 06, 2021

Presentation TCT 2021

One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions

Presenter: Bruno Scheller

November 06, 2021

Advertisement

Prevail Paclitaxel Coated Balloon

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Drug-Eluting Stent In-Stent Restenosis: A Prospective, Multicenter, Randomized Trial

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

TCT 64: Very Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon After a Bare-Metal Stent for the Treatment of ST-Elevation Myocardial Infarction: 8-Year Results of a Randomized Clinical Trial (PEBSI Study)

What’s Going to Be Hot at TCT 2023

TCTMD’s Top 10 Most Popular Stories for July 2023

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Top Endovascular News of 2022

Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Paclitaxel or Limus: What is the Future in Drug Eluting Therapies?

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

DCBs in Coronaries? Some Good News, but More Work Needed

One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content